| Authors: |
Gao L; Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Brenner D; Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Llorens-Bobadilla E; Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Saiz-Castro G; Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Frank T; Department of Neurology, University Medical Center, Georg-August-University, 37075 Göttingen, Germany., Wieghofer P; Institute of Neuropathology, Faculty of Biology, and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79098 Freiburg, Germany Institute of Neuropathology, Faculty of Biology, and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79098 Freiburg, Germany., Hill O; Apogenix GmbH, 69120 Heidelberg, Germany., Thiemann M; Apogenix GmbH, 69120 Heidelberg, Germany., Karray S; Institut National de la Santé et de la Recherche Médicale (INSERM), U1160, Université Paris Diderot, 75010 Paris, France., Prinz M; Institute of Neuropathology, Faculty of Biology, and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79098 Freiburg, Germany Institute of Neuropathology, Faculty of Biology, and BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79098 Freiburg, Germany., Weishaupt JH; Department of Neurology, University of Ulm, 89081 Ulm, Germany., Martin-Villalba A; Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany a.martin-villalba@dkfz.de. |